检索

标题
作者
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.
Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy
Mezhonov E., Reitblat O., Vyalkina Y., Airapetian A., Lazareva N., Ageev F., Blankova Z., Svirida O., Prints Y., Zhirov I., Tereshchenko S., Boytsov S.
End products of glycation (AGEs) and inflammation in the clinic of cardiovascular complications and vascular calcification at different stages of chronic kidney disease (G1–G5D)
Fatima D., Remizov O., Ikoeva Z., Tedeeva I., Gusalov A., Goloeva V.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F., Remizov O., Goloeva V., Ikoeva Z.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Fomin V.
The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media
Vasin A., Mironova O., Fomin V.
Frailty and chronic kidney disease – the real problem of modern nephrology: A review
Rudenko T., Bobkova I., Kamyshova E., Stavrovskaya E.
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus
Murkamilov I., Aitbaev K., Fomin V.
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G., Lopatin Y., Ametov A., Ageev F., Antsiferov M., Villevalde S., Vinogradova N., Galstyan G., Galyavich A., Gilyarevskiy S., Glezer M., Zhirov I., Ilyin M., Lebedeva A., Nedogoda S., Salukhov V., Tarlovskaya E., Tereshchenko S., Fomin I., Khalimov I., Khasanov N., Cherkashin D., Yakushin S.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E., Dudnikova A.
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study
Milovanova L., Taranova M., Volkov A., Milovanova S., Beketov V.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N., Moiseev S.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M., Frolova N., Kim I., Ushakova A., Usatiuk S., Iskhakov R., Diakova E., Chervinko V., Volodina E., Tomilina N., Kryukov E.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis
Markina M., Milovanova L., Lysenko L., Milovanova S., Volkov A., Beketov V., Lebedeva M., Nezhdanov K., Moiseev S.
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M., Sukhareva O., Shestakova M.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O., Orlova A., Rogozhkina E., Drapkina O.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V., Pulin A., Mukhin N.
Current challenges for therapy of comorbid patients: a new look at celecoxib. A review
Zyryanov S., Baybulatova E.
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Bobkova I.
Polyvascular disease in patients with myocardial infarction and chronic kidney disease
Karetnikova V., Kalaeva V., Evseeva M., Gruzdeva O., Zykov M., Kashtalap V., Barbarash O.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G., Tarlovskaia E., Koziolova N., Boldina M., Batiushin M., Ametov A., Arutiunov A., Belevskii A., Galstian G., Grigor’eva N., Dzhunusbekova G., Esaian A., Mal’chikova S., Mit’kovskaia N., Mkrtumian A., Orlova I., Petrova M., Rebrov A., Ruzanov D., Salukhov V., Sisakian A., Skibitskii V., Sugraliev A., Fomin I., Khalimov I., Chesnikova A., Shaposhnik I., Shestakova M.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E., Dmitriev V., Titov V.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S., Karovaikina E., Bulanov N., Moiseev A., Fomin V.
Contrast-induced acute kidney injury in chronic coronary artery disease patients with diabetes mellitus and obesity
Mironova O., Staroverov I., Sivakova O., Deev A., Fomin V.
Anemia as a risk factor of contrast-associated acute kidney injury
Mironova O., Deev A., Lakotka P., Fomin V.
Contrast-induced acute kidney injury in patients with stable coronary artery disease: the most important risk factors and prevalence
Mironova O., Staroverov I., Sivakova O., Fomin V.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N., Gulyaev S., Androsova T., Popova E., Gurova D., Novikov P., Milovanova L., Moiseev S.
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
Demyanova K., Kozlovskaya N., Korotchaeva Y., Apresyan S., Rylceva L., Usatenko G., Lugovoj A., Vorobyeva M., Bondarenko T., Bespalova A., Volkova O.
What we do and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman’s Day
Piccoli G., Alrukhaimi M., Zhi-Hong L., Zakharova E., Levin A.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N., Milovanov Y., Kozlovskaya L., Dobrosmyslov I., Milovanova L.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F., Sopoev M., Gatagonova T., Bestaeva T., Khamitsaeva O.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F., Gatagonova T., Bestaeva T., Sopoev M., Bazaeva B., Khamitsaeva O.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A., Kustova T., Fomin V., Mukhin N.
The pathogenetic bases of cardiorenal syndrome
Beloglazova I., Mogutova P., Poteshkina N.
The periprocedural myocardial infarction and probability of the developing of the contrast-induced acute kidneys injury in clinical practice. Case report
Dmitrieva O., Mironova O., Sivakova O., Denisova A., Solnceva T., Fomin V.
Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease
Taranova M., Milovanova L., Kozlovskaya(Lysenko) L., Milovanova S., Androsova T., Zubacheva D., Lebedeva M., Dobrosmyslov I., Kozlov V., Kuchieva A., Li O., Reshetnikov V.
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants
Chebotareva N., Guliaev S., Androsova T., Milivanova L.
Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy
Murkamilov I., Sabirov I., Fomin V., Yusupov F.
The role of immune factors in the progression of chronic kidney diseases in HIV infection
Yushchuk N., Gadzhikulieva M., Balmasova I., Volgina G., Gultyaev M.
Renal anemia and cardiac remodeling in patient with chronic glomerulonephritis
Murkamilov I., Lunegova O., Kaliev R.
Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region)
Nagaĭtseva S., Shaliagin I., Shvetsov M., Piagaĭ N., Ivanova E., Shilov E.
Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease
Musina N., Semenova R.
MYOCARDIAL REMODELING RISK FACTORS AT STAGE II-IV CHRONIC KIDNEY DISEASE
Rudenko T., Kutyrina I., Shvetsov M.
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery
Gussaova S., Bobkova I., Yashkov Y., Bordan N., Stavrovskaya E., Bekuzarov D., Evdoshenko V., Fedenko V., Malykhina A., Struve A.
1 - 50 的 79 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##